Dalian BIO-CHEM Company Limited (SHA:603360)
China · Delayed Price · Currency is CNY 13.45
-0.14 (-1.03%)
Aug 14, 2026, 3:00 PM CST
Dalian BIO-CHEM Company Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,186 | 1,173 | 668.24 | 539.52 | 417.96 | 293.88 |
Trading Asset Securities | 57.87 | 57.87 | 53.45 | 60.01 | - | 0.63 |
Cash & Short-Term Investments | 1,244 | 1,231 | 721.7 | 599.54 | 417.96 | 294.51 |
Cash Growth | 47.20% | 70.52% | 20.38% | 43.44% | 41.92% | -14.24% |
Accounts Receivable | 295.38 | 257.38 | 419.13 | 168.24 | 176.6 | 192.87 |
Other Receivables | 19.58 | 19.73 | 132.45 | 222.09 | 224.56 | 1.09 |
Receivables | 314.96 | 277.11 | 551.58 | 390.32 | 401.16 | 193.97 |
Inventory | 1,050 | 1,056 | 925.76 | 206.94 | 181.04 | 186.73 |
Other Current Assets | 137.42 | 73.44 | 390.85 | 70.64 | 50.32 | 52.56 |
Total Current Assets | 2,746 | 2,637 | 2,590 | 1,267 | 1,050 | 727.77 |
Property, Plant & Equipment | 675.88 | 689.67 | 696.43 | 619.51 | 630.4 | 825.83 |
Long-Term Investments | 147.4 | 150.07 | - | 7.02 | 13.89 | - |
Goodwill | 230.53 | 230.53 | 230.53 | - | - | - |
Other Intangible Assets | 120.57 | 124.14 | 137.21 | 42.17 | 43.18 | 92.16 |
Long-Term Deferred Tax Assets | 26.35 | 24.5 | 31.52 | - | 11.2 | 17.82 |
Long-Term Deferred Charges | 27.42 | 28.82 | 25.74 | - | - | 0.55 |
Other Long-Term Assets | 15.03 | 10.09 | 8.42 | 5.58 | 5.24 | 6.59 |
Total Assets | 3,989 | 3,895 | 3,720 | 1,942 | 1,754 | 1,671 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 81.55 | 88.38 | 117.72 | 62.64 | 66.77 | 142.02 |
Accrued Expenses | 17.07 | 36.64 | 30.62 | 16.09 | 17.86 | 14.26 |
Short-Term Debt | 305.94 | 255.96 | 423.94 | 150.01 | 129.11 | 338.5 |
Current Portion of Long-Term Debt | 281.74 | 273.09 | 29 | - | - | - |
Current Portion of Leases | - | 10.72 | 6.49 | 0.4 | - | - |
Current Income Taxes Payable | 30.94 | 27.41 | 45.86 | 13.93 | - | 0.16 |
Current Unearned Revenue | 174.57 | 149.69 | 388.85 | 2.35 | 2.15 | 4.37 |
Other Current Liabilities | 69.09 | 77.22 | 110.98 | 24.38 | 24.96 | 37.56 |
Total Current Liabilities | 960.9 | 919.1 | 1,153 | 269.8 | 240.86 | 536.89 |
Long-Term Debt | 830.59 | 783.31 | 86 | - | - | - |
Long-Term Leases | 23.71 | 20.83 | 22.6 | 0.38 | - | - |
Long-Term Unearned Revenue | 79.03 | 79.52 | 8.06 | 9.34 | 10.63 | 37.32 |
Long-Term Deferred Tax Liabilities | 38.97 | 40.57 | 53.38 | 25.46 | 41.63 | 36.85 |
Other Long-Term Liabilities | 2.78 | 12.76 | 6.49 | - | - | 10 |
Total Liabilities | 1,936 | 1,856 | 1,330 | 304.99 | 293.12 | 621.07 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 706.22 | 706.22 | 504.45 | 360.32 | 258.95 | 261.35 |
Additional Paid-In Capital | 141.77 | 141.7 | 97.03 | 78.96 | 129.71 | 139.68 |
Retained Earnings | 970.83 | 950.41 | 1,245 | 1,214 | 1,190 | 787.04 |
Treasury Stock | -400.02 | -400.02 | - | -10.53 | -117.72 | -138.56 |
Comprehensive Income & Other | -8.76 | -10.34 | -11.58 | -5.67 | 0.66 | 0.15 |
Total Common Equity | 1,410 | 1,388 | 1,835 | 1,637 | 1,461 | 1,050 |
Minority Interest | 643.42 | 650.68 | 554.78 | - | - | - |
Shareholders' Equity | 2,053 | 2,039 | 2,390 | 1,637 | 1,461 | 1,050 |
Total Liabilities & Equity | 3,989 | 3,895 | 3,720 | 1,942 | 1,754 | 1,671 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,442 | 1,344 | 568.03 | 150.79 | 129.11 | 338.5 |
Net Cash (Debt) | -197.62 | -113.25 | 153.66 | 448.74 | 288.85 | -44 |
Net Cash Growth | - | - | -65.76% | 55.36% | - | - |
Net Cash Per Share | -0.29 | -0.16 | 0.22 | 0.64 | 0.42 | -0.06 |
Filing Date Shares Outstanding | 660.95 | 691.63 | 706.22 | 701.37 | 696.35 | 701.64 |
Total Common Shares Outstanding | 660.95 | 691.63 | 706.22 | 701.37 | 696.35 | 701.64 |
Working Capital | 1,785 | 1,718 | 1,436 | 997.63 | 809.62 | 190.88 |
Book Value Per Share | 2.13 | 2.01 | 2.60 | 2.33 | 2.10 | 1.50 |
Tangible Book Value | 1,059 | 1,033 | 1,467 | 1,595 | 1,418 | 957.5 |
Tangible Book Value Per Share | 1.60 | 1.49 | 2.08 | 2.27 | 2.04 | 1.36 |
Buildings | - | 356.02 | 356 | 352.23 | 329.53 | 413.34 |
Machinery | - | 750.06 | 661.21 | 569.13 | 547.95 | 575.64 |
Construction In Progress | - | 2.12 | 25.39 | 1.21 | 0.22 | 88.14 |